drugset / Trial / NCT00617513
Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine which dose of prucalopride is safe and effective in patients with chronic idiopathic constipation. Hypothesis: Prucalopride 1 and 2 mg are safe and effective for the treatment of chronic idiopathic constipation whereas 0,5 mg is a suboptimal dose.
Timeline
- Start
- 1995-03
- Primary completion
- 1996-03
- Completion
- 1996-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 0.5 mg | Oral |
| Comparator | Prucalopride | Small molecule | 1 mg | Oral |
| Comparator | Prucalopride | Small molecule | 2 mg | Oral |